Skye Bioscience, Inc. Retained Earnings
Skye Bioscience, Inc. (SKYE) had Retained Earnings of -$210.17 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$210.17M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$199.38M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$186.87M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$172.43M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$210.17M 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$199.38M 10-Q · filed 2026-05-11 |
| 2025-12-31 | -$186.87M 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$172.43M 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$159.68M 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$142.05M 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$130.95M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$121.20M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$117.30M 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$109.40M 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$104.38M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$99.96M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$75.02M 10-Q · filed 2023-08-07 |
| 2023-03-31 | -$71.91M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$66.74M 10-K · filed 2024-03-22 |
| 2022-09-30 | -$56.85M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$53.72M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$50.30M 10-Q · filed 2022-05-06 |
| 2021-12-31 | -$47.26M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$44.74M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$42.92M 10-Q · filed 2021-08-06 |
| 2021-03-31 | -$40.89M 10-Q · filed 2021-05-07 |
| 2020-12-31 | -$38.73M 10-K · filed 2022-03-28 |
| 2020-09-30 | -$37.23M 10-Q · filed 2020-11-06 |
| 2020-06-30 | -$35.94M 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$34.51M 10-Q · filed 2020-05-08 |
| 2019-12-31 | -$32.17M 10-K · filed 2021-03-02 |
| 2019-09-30 | -$37.03M 10-Q · filed 2019-11-14 |
| 2019-06-30 | -$32.09M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$48.00M 10-Q · filed 2019-05-10 |
| 2018-12-31 | -$33.23M 10-K · filed 2020-03-23 |
| 2018-09-30 | -$27.00M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$24.91M 10-Q · filed 2018-08-10 |
| 2018-03-31 | -$22.24M 10-Q · filed 2018-05-15 |
| 2017-12-31 | -$14.03M 10-K · filed 2019-03-14 |
| 2017-09-30 | -$13.40M 10-Q · filed 2017-11-14 |
| 2017-06-30 | -$12.92M 10-Q · filed 2017-08-11 |
| 2017-03-31 | -$12.22M 10-Q · filed 2017-05-12 |
| 2016-12-31 | -$10.94M 10-K · filed 2018-03-19 |
| 2016-09-30 | -$9.82M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$8.87M 10-Q · filed 2016-08-12 |
| 2016-03-31 | -$9.44M 10-Q · filed 2016-05-13 |
| 2015-12-31 | -$7.76M 10-K · filed 2017-03-10 |
| 2015-09-30 | -$7.07M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$5.88M 10-Q · filed 2015-08-14 |
| 2014-12-31 | -$2.92M 10-K · filed 2016-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |